BlackRock, Inc. 13D and 13G filings for Alnylam Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 5:25 pm Sale |
2023-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BLACKROCK INC BLK |
8,546,557 6.800% |
-119,145 (-1.37%) |
Filing |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BLACKROCK INC BLK |
8,665,702 7.000% |
994,300 (+12.96%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BLACKROCK INC BLK |
7,671,402 6.400% |
-1,052,318 (-12.06%) |
Filing |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BLACKROCK INC BLK |
8,723,720 7.500% |
690,464 (+8.60%) |
Filing |